(No Longer Accepting Cases) Popular Diabetes Medication Invokana Linked to Amputations, and Other Severe Injuries Invokana, canagliflozin, is prescribed to millions of patients across the globe, earning drug maker Johnson & Johnson about $1.3 billion in 2015. Despite how popular the medication is, patients are suffering serious adverse events, including foot, and toe and … [Read more...]